Literature DB >> 8957958

Successful treatment of non-familial haemophagocytic lymphohistiocytosis with interferon and gammaglobulin.

E J Estlin1, R D Palmer, K P Windebank, M F Lowry, A D Pearson.   

Abstract

Two cases of non-familial haemophagocytic lymphohistiocytosis (HLH) are presented in which treatment with interferon alfa and gammaglobulin was associated with complete clinical remission. In one case, serological evidence of recent Epstein-Barr virus infection was found. Natural killer cell activity was within normal limits in both children, compatible with a secondary form of HLH. The combination of interferon alfa and intravenous gammaglobulin requires further evaluation in the treatment of non-familial HLH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957958      PMCID: PMC1511773          DOI: 10.1136/adc.75.5.432

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis.

Authors:  R Eife; G E Janka; B H Belohradsky; H Holtmann
Journal:  Pediatr Hematol Oncol       Date:  1989       Impact factor: 1.969

2.  Soluble interleukin-2 receptor in hemophagocytic histiocytoses: searching for markers of disease activity.

Authors:  D M Komp; P J Buckley; J McNamara; J van Hoff
Journal:  Pediatr Hematol Oncol       Date:  1989       Impact factor: 1.969

3.  Intravenous immunoglobulin in virus associated haemophagocytic syndrome.

Authors:  P Goulder; D Seward; C Hatton
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

4.  Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer.

Authors:  M M Hawkins; L M Wilson; M A Stovall; H B Marsden; M H Potok; J E Kingston; J M Chessells
Journal:  BMJ       Date:  1992-04-11

5.  Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.

Authors:  R S Shapiro; A Chauvenet; W McGuire; A Pearson; A W Craft; P McGlave; A Filipovich
Journal:  N Engl J Med       Date:  1988-05-19       Impact factor: 91.245

Review 6.  Hematophagic histiocytosis. A report of 23 new patients and a review of the literature.

Authors:  A P Reiner; J L Spivak
Journal:  Medicine (Baltimore)       Date:  1988-11       Impact factor: 1.889

7.  Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

Authors:  R J Risdall; R W McKenna; M E Nesbit; W Krivit; H H Balfour; R L Simmons; R D Brunning
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

8.  Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden.

Authors:  P Bolme; J I Henter; J Winiarski; G Elinder; P Ljungman; G Lönnerholm; O Ringdén
Journal:  Bone Marrow Transplant       Date:  1995-03       Impact factor: 5.483

9.  Hypercytokinemia in familial hemophagocytic lymphohistiocytosis.

Authors:  J I Henter; G Elinder; O Söder; M Hansson; B Andersson; U Andersson
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

10.  Haemophagocytic lymphohistiocytosis: experience at two U.K. centres.

Authors:  W J Hirst; D M Layton; S Singh; G Mieli-Vergani; J M Chessells; S Strobel; J Pritchard
Journal:  Br J Haematol       Date:  1994-12       Impact factor: 6.998

View more
  3 in total

1.  Reactive haemophagocytic lymphohistiocytosis.

Authors:  Shanto Pramanik; Priyankar Pal; P K Das; Subroto Chakrabarty; Arpita Bhattacharya; Sushmita Banerjee
Journal:  Indian J Pediatr       Date:  2009-04-16       Impact factor: 1.967

2.  Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocytic lymphohistiocytosis syndrome*.

Authors:  Dennis W Simon; Rajesh Aneja; Joseph A Carcillo; E Scott Halstead
Journal:  Pediatr Crit Care Med       Date:  2014-06       Impact factor: 3.624

3.  Fatal parvovirus B19 infections: a report of two autopsy cases.

Authors:  Hsuan-Yun Hu; Shyh-Yuh Wei; Wei-Hsiang Huang; Chih-Hsin Pan
Journal:  Int J Legal Med       Date:  2018-09-01       Impact factor: 2.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.